stockportfolio.pro
Stocks / ADCT vs CATX
ADCT vs CATX
ADC Therapeutics SA and Perspective Therapeutics, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| ADC Therapeutics SA (ADCT) | Perspective Therapeutics, Inc. (CATX) | |
|---|---|---|
| Market cap | $0.1B | $0.3B |
| Revenue (latest FY) | $81.36M | $884,000 |
| Net income (latest FY) | $-142.62M | $-103.12M |
| Revenue growth (5y CAGR) | -27.1% | -38.5% |
| Net margin | -175.3% | -11665.3% |
| Return on equity | 76.7% | -49.8% |
| P/E ratio | — | — |
| Dividend yield | — | — |
| Profitable years (of last 10) | 0 | 0 |
| Positive free cash flow | No | No |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open ADCT — free Open CATX — freeFrequently asked questions
Which is bigger, ADCT or CATX?
Perspective Therapeutics, Inc. is larger by market capitalization — $0.3B versus $0.1B.
Which grows faster, ADCT or CATX?
Over the last five fiscal years, ADC Therapeutics SA grew revenue faster — -27.1%/yr versus -38.5%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.